Ultrasound monitoring of hepatic metastases during chemotherapy.Br Med J 1975; 1 doi: https://doi.org/10.1136/bmj.1.5954.371 (Published 15 February 1975) Cite this as: Br Med J 1975;1:371
- E D Gilby,
- K J Taylor
Grey-scale ultrasonography has been found to be the most sensitive method of detecting metastatic disease of the liver. In two cases the results of chemotherapy were monitored by ultrasound; the response to treatment could be distinguished from non-response and ultrasonography gave useful information when chemotherapy made radioisotope examination unreliable.